New research network funding could benefit pharma
UK, France and Germany to set up new research team networks
The EU pharmaceutical sector will benefit from two new networks of research teams that will, with a third environmental study group, benefit from b700m of European Commission funding.
The first will be established by the UK and will focus on systems biology; and the second, set up by France and Germany, will focus on human infections and related issues.
